American Tower Analyst Price Targets

Wall Street analyst price targets and consensus rating for American Tower (AMT).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

4S.Buy

14Buy

1Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$223Upside to Avg. PT+25.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 28, 2026	RBC Capital	David Paige	Maintained	Outperform	$205
Oct 20, 2026	Bernstein	Madison Rezaei	PT Cut	Outperform	$214→$212
Sep 30, 2026	Barclays	Brendan Lynch	PT Raise	Overweight	$198→$199
Aug 20, 2026	Barclays	Brendan Lynch	Upgrade	Equal-Weight→Overweight	$195→$198
Aug 12, 2026	Truist Securities	Matthew Niknam	PT Cut	Buy	$208→$207
Jul 29, 2026	TD Cowen	Michael Elias	PT Raise	Buy	$225→$227
Jul 29, 2026	BMO Capital	Ari Klein	PT Raise	Market Perform	$190→$195
Jul 9, 2026	Wolfe Research	Andrew Rosivach	Upgrade	Peer Perform→Outperform	$188
Jun 26, 2026	Goldman Sachs	Michael Ng	Assumes	Buy	$215
Jun 26, 2026	RBC Capital	Jonathan Atkin	Upgrade	Sector Perform→Outperform	$195→$205
May 19, 2026	Bernstein	Madison Rezaei	Upgrade	Market Perform→Outperform	$207
Apr 30, 2026	RBC Capital	Jonathan Atkin	Maintained	Sector Perform	$195
Apr 30, 2026	Truist Securities	Matthew Niknam	PT Raise	Buy	$205→$208
Apr 29, 2026	JP Morgan	Richard Choe	PT Cut	Overweight	$245→$240
Apr 29, 2026	Scotiabank	Maher Yaghi	PT Raise	Sector Outperform	$214→$218
Apr 29, 2026	Citizens	Greg P. Miller	Maintained	Market Outperform	$260
Apr 16, 2026	Barclays	Tim Long	PT Cut	Equal-Weight	$200→$195
Apr 15, 2026	Mizuho	Vikram Malhorta	Upgrade	Neutral→Outperform	$189→$205
Mar 31, 2026	Truist Securities	Matthew Niknam	Initiate	Buy	$205
Mar 5, 2026	Bernstein	Madison Rezaei	Initiate	Market Perform	$205

Analyst Ratings News

PRO
RBC Capital Reiterates Outperform on American Tower, Maintains $205 Price Target

RBC Capital analyst David Paige reiterates American Tower (NYSE:AMT) with a Outperform and maintains $205 price target.

Benzinga Newsdesk

PRO
CNBC Halftime Report Final Trades: Apple, UnitedHealth Group, Delta Air Lines, American Tower

Benzinga Newsdesk

SpaceX Is Killing Telecom Stocks: IYZ ETF Hits Longest Losing Streak Ever Against the S&P 500

IYZ telecom ETF lagged SPY for 12 sessions, its longest run since 2000, as SpaceX moves into U.S. wireless. AT&T, Verizon, T-Mobile slide premarket.

Piero Cingari

PRO
Bernstein Maintains Outperform on American Tower, Lowers Price Target to $212

Bernstein analyst Madison Rezaei maintains American Tower (NYSE:AMT) with a Outperform and lowers the price target from $214 to $212.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on American Tower, Raises Price Target to $199

Barclays analyst Brendan Lynch maintains American Tower (NYSE:AMT) with a Overweight and raises the price target from $198 to $199.

Benzinga Newsdesk

PRO
Barclays Upgrades American Tower to Overweight, Raises Price Target to $198

Barclays analyst Brendan Lynch upgrades American Tower (NYSE:AMT) from Equal-Weight to Overweight and raises the price target from $195 to $198.

Benzinga Newsdesk

American Tower Corp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

American Tower Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
RBC Capital Reiterates Outperform on American Tower, Maintains $205 Price Target

PRO
CNBC Halftime Report Final Trades: Apple, UnitedHealth Group, Delta Air Lines, American Tower

SpaceX Is Killing Telecom Stocks: IYZ ETF Hits Longest Losing Streak Ever Against the S&P 500

PRO
Bernstein Maintains Outperform on American Tower, Lowers Price Target to $212

PRO
Barclays Maintains Overweight on American Tower, Raises Price Target to $199

PRO
Barclays Upgrades American Tower to Overweight, Raises Price Target to $198

People Also Watch

People Also Watch

American Tower Corp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

American Tower Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORBC Capital Reiterates Outperform on American Tower, Maintains $205 Price Target

PROCNBC Halftime Report Final Trades: Apple, UnitedHealth Group, Delta Air Lines, American Tower

SpaceX Is Killing Telecom Stocks: IYZ ETF Hits Longest Losing Streak Ever Against the S&P 500

PROBernstein Maintains Outperform on American Tower, Lowers Price Target to $212

PROBarclays Maintains Overweight on American Tower, Raises Price Target to $199

PROBarclays Upgrades American Tower to Overweight, Raises Price Target to $198

People Also Watch

People Also Watch

PRO
RBC Capital Reiterates Outperform on American Tower, Maintains $205 Price Target

PRO
CNBC Halftime Report Final Trades: Apple, UnitedHealth Group, Delta Air Lines, American Tower

PRO
Bernstein Maintains Outperform on American Tower, Lowers Price Target to $212

PRO
Barclays Maintains Overweight on American Tower, Raises Price Target to $199

PRO
Barclays Upgrades American Tower to Overweight, Raises Price Target to $198